ProfileGDS4718 / 225172_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 71% 76% 72% 71% 73% 76% 73% 67% 66% 67% 62% 71% 74% 72% 66% 69% 76% 71% 79% 68% 68% 68% 66% 71% 73% 69% 81% 70% 76% 75% 76% 70% 70% 76% 70% 75% 72% 71% 76% 70% 76% 74% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.788269
GSM549102patient 115, normal, homogenized [OPG study]6.9422271
GSM549104patient 119, normal, homogenized [OPG study]7.5053176
GSM549108patient 138, normal, homogenized [OPG study]7.0009772
GSM549119patient 077, normal, homogenized [OPG study]6.8985271
GSM549133patient 032, cancer, homogenized [OPG study]7.2499773
GSM549139patient 042, cancer, homogenized [OPG study]7.4752776
GSM549099patient 107, normal, homogenized [OPG study]7.067673
GSM549109patient 139, normal, homogenized [OPG study]6.620767
GSM549110patient 046, normal, homogenized [OPG study]6.5613766
GSM549114patient 063, normal, homogenized [OPG study]6.566667
GSM549122patient 082, normal, homogenized [OPG study]6.2812262
GSM549134patient 033, cancer, homogenized [OPG study]6.944971
GSM549136patient 036, cancer, homogenized [OPG study]7.3417674
GSM549140patient 044, cancer, homogenized [OPG study]7.0874972
GSM549111patient 047, normal, homogenized [OPG study]6.5921266
GSM549113patient 057, normal, homogenized [OPG study]6.8123769
GSM549132patient 031, cancer, homogenized [OPG study]7.4203776
GSM549137patient 038, cancer, homogenized [OPG study]6.9647371
GSM549142patient 047, cancer, homogenized [OPG study]7.5660779
GSM549100patient 110, normal, homogenized [OPG study]6.7091168
GSM549107patient 135, normal, homogenized [OPG study]6.7230268
GSM549115patient 068, normal, homogenized [OPG study]6.7373368
GSM549116patient 072, normal, homogenized [OPG study]6.5640466
GSM549120patient 078, normal, homogenized [OPG study]6.9954871
GSM549131patient 030, cancer, homogenized [OPG study]7.2714273
GSM549118patient 074, normal, homogenized [OPG study]6.7618369
GSM549129patient 027, cancer, homogenized [OPG study]8.0247481
GSM549123patient 088, normal, homogenized [OPG study]6.9215270
GSM549124patient 006, cancer, homogenized [OPG study]7.3419176
GSM549126patient 015, cancer, homogenized [OPG study]7.3476175
GSM549128patient 025, cancer, homogenized [OPG study]7.4653476
GSM549103patient 117, normal, homogenized [OPG study]6.8310770
GSM549117patient 073, normal, homogenized [OPG study]6.8270970
GSM549138patient 041, cancer, homogenized [OPG study]7.4473276
GSM549141patient 045, cancer, homogenized [OPG study]6.9619570
GSM549130patient 028, cancer, homogenized [OPG study]7.2795275
GSM549101patient 111, normal, homogenized [OPG study]7.0050572
GSM549105patient 128, normal, homogenized [OPG study]6.9463471
GSM549106patient 134, normal, homogenized [OPG study]7.5180776
GSM549112patient 048, normal, homogenized [OPG study]6.8256470
GSM549125patient 011, cancer, homogenized [OPG study]7.4391576
GSM549127patient 024, cancer, homogenized [OPG study]7.3411774
GSM549135patient 035, cancer, homogenized [OPG study]7.5761776